Acute myopathy after liver transplantation

Neurology

Volumn 50, Issue 1, 1998, Pages 46-53

  Campellone, J V ^a,d   Lacomis, D ^b   Kramer, D J ^b   Van Gott, A C ^c   Giuliani, M J ^c  

^a Department of Neurology ^*  (United States)

^b Division of Neuropathology   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CRITICAL ILLNESS; ELECTRODIAGNOSIS; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCLE WEAKNESS; MYOFILAMENT; MYOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; AGED; INCIDENCE; MIDDLE AGED; MORTALITY; MUSCLE DISEASE; MUSCLE FIBRIL; NEEDLE BIOPSY; PARESIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR; ULTRASTRUCTURE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; ELECTRODIAGNOSIS; FEMALE; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUSCULAR DISEASES; MYOFIBRILS; PARESIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0031603375     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.46     Document Type: Article

References (43)

1. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet 1977;2:615.
2. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-1139.
3. Douglass JA, Tuxen DV, Home M, et al. Myopathy in severe asthma. Am Rev Respir Dis 1992;146:517-519.
4. Griffin D, Fairman N, Coursin D, Rawsthorne L, Grossman JE. Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. Chest 1992;102:510-14.
5. Lacomis D, Smith TW, Chad DA. Acute myopathy and neuropathy in status asthmaticus: case report and review of the literature. Muscle Nerve 1993;16:84-90.
6. Sandrock AW. Weekly clinicopathological exercises, Case 111997. N Engl J Med 1997;336:1079-1088.
7. Faragher MW, Day BJ, Dennett X. Critical care myopathy: an electrophysiological and histological study. Muscle Nerve 1996;19:516-518.
8. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996;40:645-654.
9. Subramony SH, Carpenter DE, Raju S, Pride M, Evans OB. Myopathy and prolonged neuromuscular blockade after lung transplant. Grit Care Med 1991;19:1580-1582.
10. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-736.
11. Zochodne DW, Ramsay DA, Saly V, Shelley S, Moffatt S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994;17:285-292.
12. Kimura J. Electrodiagnosis in diseases of nerve and muscle, 2nd edition. Philadelphia: FA Davis, 1989.
13. Coté AM, Jiménez L, Adelman LS, Munsat TL. Needle muscle biopsy with the automatic Biopty instrument. Neurology 1992;42:2212-2213.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE-II: a severity of disease classification system. Grit Care Med 1985;13:818-829.
15. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA. Neurological complications following liver transplantation. Ann Neurol 1992;31:644-649.
16. Moreno E, Gomez SR, Gonzalez I, et al. Neurologic complications in liver transplantation. Acta Neurol Scand 1993; 87:25-31.
17. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703.
18. Martinez AJ, Estol C, Paris AA. Neurologic complications of liver transplantation. Neurol Clin 1988;6:327-348.
19. Guarino M, Stracciari A, Pazzaglia P, et al. Neurological complications of liver transplantation. J Neurol 1996;243:137142.
20. Wijdicks EFM, Litchy WJ, Wiesner RH, Krom RAF. Neuromuscular complications associated with liver transplantation. Muscle Nerve 1996;19:696-700.
21. Hansen-Flaschen J, Cowen J, Raps EC. Neuromuscular blockade in the intensive care unit: more than we bargained for. Am Rev Respir Dis 1993;147:234-236.
22. Raps EC, Bird SJ, Hansen-Flaschen J. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit. Crit Care Clin 1994;10:799-813.
23. Chad DA, Lacomis D. Critically ill patients with newly ac-quired weakness: the clinicopathological spectrum. Ann Neurol 1994;35:257-259.
24. Hund EF. Neuromuscular complications in the ICU: the spectrum of critical illness-related conditions causing muscular weakness and weaning failure. J Neurol Sci 1996;136:10-16.
25. Zochodne DW, Bolton OF, Wells GA, et al. Critical illness polyneuropathy: a complication of sepsis and multiorgan failure. Brain 1987;110:819-841.
26. Widjicks EFM, Litchy WJ, Harrison BA, Gracey DR. The clinical spectrum of critical illness neuropathy. Mayo Clin Proc 1994;69:955-959.
27. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after longterm infusion of vecuronium in two critically ill patients. Anesthesiology 1990;72:566-570.
28. Partridge BL, Abrams JH, Bazemore C, Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990; 18:1177-1179.
29. Giostra E, Magistris MR, Pizzolato G, Cox J, Chevrolet J. Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Chest 1994;106:210-220.
30. Gutmann L, Blumenthal D, Gutmann L, Schochet SS. Acute type II myofiber atrophy in critical illness. Neurology 1996;46: 819-821.
31. Rouleau G, Karpati G, Carpenter S, et al. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987;10:428-438.
32. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992; 15:1290-1298.
33. Caldwell JE. New skeletal muscle relaxants. Int Anesth Clin 1995;33:39-61.
34. Shee CD. Risk factors for hydrocortisone myopathy in acute severe asthma. Resp Med 1990;84:229-233.
35. The U.S. Multicenter FK-506 Liver Study Group. A comparison of tacrolimus (FK-506) and cyclosporin for immunosuppression in liver transplantation. N Engl J Med 1994;331: 1110-1115.
36. European FK-506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK-506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994;344:423428.
37. Larner AJ, Sturman SG, Hawkins JB, Andersen M. Myopathy with ragged red fibers following renal transplantation: possible role of cyclosporin-induced hypomagnesemia. Acta Neuropathol 1994;88:189-192.
38. Chassagne P, Mejjad O, Moore N, et al. Myopathy as possible side-effect of cyclosporin. Lancet 1989;2:1104.
39. Low PA, Tuck RR, Takeuchi M. Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, et al., eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1987:268-277.
40. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99: 176-184.
41. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Grit Care Med 1992;20:864-874.
42. Angus DC, Colantonio A, Kramer DJ, et al. Outcome prediction with the APACHE-II system in liver transplantation. Grit Care Med 1993;21:S176.
43. Kramer DJ, Angus DC, Colantonio A, et al. Outcome prediction for end-stage liver disease using APACHE-II score is affected by liver transplantation. Grit Care Med 1993;21: S233.